Financial statements Evaclinic Group
Balance sheet data of EVACLINIC GROUP
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 2 341 652,91 | 1 851 066,77 | 1 120 982,32 | 768 327,62 | 440 871,11 | 140 616,18 |
| A. Fixed assets | 1 849 374,68 | 1 480 629,56 | 1 070 902,74 | 652 170,77 | 381 588,29 | 90 077,76 |
| B. Current assets | 492 278,23 | 370 437,21 | 50 079,58 | 116 156,85 | 59 282,82 | 50 538,42 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 2 341 652,91 | 1 851 066,77 | 1 120 982,32 | 768 327,62 | 440 871,11 | 140 616,18 |
| A. Equity | -1 518 128,02 | -1 798 466,64 | -2 238 793,98 | -2 285 077,53 | -2 556 327,16 | -370 720,46 |
| B. Liabilities and provisions for liabilities | 3 859 780,93 | 3 649 533,41 | 3 359 776,30 | 3 053 405,15 | 2 997 198,27 | 511 336,64 |
| I. Long-term liabilities | 2 416 859,54 | 2 539 798,24 | 3 129 047,84 | 2 817 524,84 | 2 794 847,21 | 327 569,85 |
| II. Short-term liabilities | 1 231 979,36 | 1 107 810,81 | 228 266,98 | 233 955,95 | 199 341,72 | 183 766,79 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.